The Center for Disease Control and Prevention (CDC) in the United States has recommended laboraties across the country adopt FDA approved multiplexed alterantives.
The PCR test is used in New Zealand, and most other countries, to determine COVID infection. Test result numbers have been used for two years by the government and media to drive COVID fear and propaganda.
Misgivings about the reliability of the PCR technology have been voiced for some time by many leading scientific and medical practitioners, including the inventor of the test himself, Professor Kary Mullis, who received a Nobel Prize for the invention. Before his untimely death in August 2019, Mullis went to great lengths to explain in public that the test was not designed to detect infectious diseases. Kiwi Dr. Sam Bailey has also been a vocal critic of the test. Daily Telegraph New Zealand and other independent media have also published articles which question the use of the test.
The CDC website reported:
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season.
The PCR test directive was issued on 31 December. It comes a day after another directive in which the CDC stated it no longer required PCR testing at the end of an isolation period, because PCR test results can stay positive for up to 12 weeks. Because of their hypersensitivity, the PCR process can show a postive result for COVID in those who have not been infectious for months, or who never had COVID in the first place. The risk of providing a ‘false positive’ result was too high.